Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessing the Prevalence of Depression Among English- and Spanish-Speaking Patients at a Free Medical Clinic.

Cureus·2025

Same author

Synergistic Combinations of Native Australian Plants For Skin Inflammation and Wound Healing.

Biomedicines·2025

Same author

Development of the Australian Rheumatology Association Clinical Care Standard for the Diagnosis and Management of Rheumatoid Arthritis in Adults.

The Journal of rheumatology·2025

Same author

A co-designed evaluation study to identify Breastfeeding Knowledge of General Practitioners' and Practice Nurses'.

Health promotion international·2024

Same author

The Effectiveness of a Mobile Health Clinic Delivering Mandatory and Elective Middle School Immunizations: A Descriptive Analysis.

Cureus·2023

Same author

An Evaluation of Knowledge and Comfort in Discussing the Human Papillomavirus (HPV) Vaccine Among a Sample of Physicians Practicing in South Carolina.

Cureus·2023

Search research articles

Related Experiment Video

Updated: Jun 25, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Pulmonary Cryptococcosis: A Diagnostic and Management Challenge Case Report.

Kylee Cardoso¹, Lisa Carroll²

¹Infectious Disease, Edward Via College of Osteopathic Medicine-Carolinas, Spartanburg, USA.

|May 31, 2024

Summary

Diagnosing and treating pulmonary cryptococcosis (fungal lung infection) is challenging, as symptoms and imaging often mimic bacterial pneumonia, complicating patient care and requiring further research.

Keywords:

cryptococcal pneumonia cryptococcosis cryptococcus gattii cryptococcus neoformans (c. neoformans)fungal infection india ink pneumonia pulmonary cryptococcal infection pulmonary cryptococcosis pulmonary cryptococcus

More Related Videos

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Experiment Videos

Last Updated: Jun 25, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Area of Science:

Mycology
Infectious Diseases
Pulmonology

Background:

Cryptococcosis is a fungal infection affecting both immunocompromised and immunocompetent individuals.
Early diagnosis and effective treatment of pulmonary cryptococcosis can be challenging due to non-specific clinical and radiographic presentations.

Observation:

A 56-year-old female with cirrhosis presented with symptoms mimicking bacterial pneumonia, including abdominal pain, dyspnea, vomiting, and diarrhea.
Initial antibiotic therapy for presumed bacterial pneumonia was ineffective, prompting further investigation.

Findings:

Pulmonary cryptococcosis was confirmed via lung biopsy after initial misdiagnosis.
Antifungal therapy led to adverse effects and limited clinical improvement, highlighting treatment difficulties.

Implications:

This case underscores the diagnostic and therapeutic challenges posed by pulmonary cryptococcosis.
Further exploration of optimal diagnostic strategies and management protocols for cryptococcal pneumonia is warranted.